Blogs & Articles

AI boosts brightfield imaging for fast, label-free cell analysis.

This article discusses how Indian CROs are driving a new era in pharmaceutical R&D, leveraging AI, data-driven insights,

Discover six key best practices that help medical monitors detect risks early in clinical trials by leveraging data-driven in

Discover how Revvity Signals' dedicated Customer Experience team helps clients build robust, efficient, and cost-effective research operations through expert support, innovative SaaS solutions, and a customer-first approach.

This article discusses the critical importance of centralized data management tools in improving research efficiency within the FAIR (Findable, Accessible, Interoperable, and Reusable) data landscape.

AI and integrated software capabilities are shaping the way scientists conduct research. Read how Josh Bond explains Revvity Signals' vision for the future of scientific research.

This article highlights the role of data strategies in accelerating the development of new drug modalities

This article highlights the importance of unifying and contextualizing drug discovery data to harness the full potential of advanced analytics.

This article highlights the critical role of an AI-ready data strategy in drug discovery, emphasizing that AI is only as effective as the quality of data it processes.

This article explores how AI and ML are revolutionizing drug discovery by enhancing data accessibility, automating chemical reaction recommendations, and improving cellular imaging.

Revvity Signal understands the opportunities that accompany creating the lab of the future. Our SaaS solutions helps businesses leverage modern technologies, including AI and ML.

This article discusses the role of digital tools like the Signals Research Suite in optimizing biosimilar development by streamlining data capture, analysis, and collaboration.